Jump to content

Ensis01

Members
  • Posts

    285
  • Joined

  • Last visited

  • Days Won

    23
  • Country

    United States

Everything posted by Ensis01

  1. Test a K+ or k+ DTT treated cell by your normal method, if you have a choice use the quickest method.
  2. This policy is for serological crossmatches; it ensures the correct ABO for the specimen on the tech's board (rack). For electronic crossmatch the ABO is checked by the computer when the product is selected, which makes a manual ABO retype by a tech redundant. The purpose ticks the boxes for speed, efficiency and cost.
  3. When wrong blood, wrong tube events are identified and the patient has already been transfused; what (other) different methods can doctors use to manage and treat this type of scenario? How quickly must they be implemented and how successful are the outcomes?
  4. Agreed Malcolm; much more efficient. That being said, if titers are few and far between in the lab testing in parallel may be easier to monitor and review.
  5. I was taught that testing titers in parallel with the previous specimen is primarily done so that any change in titer can be objectively compared; you are using the same cell of the same age with both specimens at the same time with the same tech. The secondary reason was to monitor and so minimize tech variability i.e. plus or minus one titer from the last techs results.
  6. Issue products until the specimen expires, the BB LISS therefore has the pertinent records that can be checked. Same principle as when issuing products until just before they expire, think platelets close to midnight. The infusion timeframe is under nursing SOPs.
  7. It seems that any tube system hand off documentation is to ensure blood is not forgotten in the nurses tube station due to other stuff happening on a busy floor.
×
×
  • Create New...

Important Information

We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.